Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma

NCT07736950

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

NCT07748689

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

NCT07749976

Conditions: Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)

NCT07712588

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Cancer Hospital of Shandong Frist Medical University Jinan, Shangdong, China

View Trial Details

Not yet recruiting

Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

NCT07526597

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Not yet recruiting

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

NCT07524634

Conditions: Amyloid Light-chain Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Not yet recruiting

The Efficacy of CAPCT in Patients With PTCL

NCT07746245

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

NCT07748364

Conditions: Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Not yet recruiting

Targeting IRAK4 in Chronic Lymphocytic Leukemia

NCT07741695

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

ReSeT in ALL 2: A Randomized, Controlled Pilot Trial Testing an Optimized, Multi-component Mobile Health Intervention to Reduce Sedentary Time in Early Adolescents and Young Adults (eAYAs) With ALL During Maintenance Therapy

NCT07742891

Conditions: Acute Lymphoblastic Leukemia (ALL), Behavior, Cardiometabolic Health, +13 more
Locations: Not specified

View Trial Details